alexion pharmaceuticals inc
Transactions by ALEXION PHARMACEUTICALS INC (ALXN) in the last 6 months
Alexion Pharmaceuticals, Inc. (NasdaqGS:ALXN) entered into a definitive agreement to acquire Synageva BioPharma Corp. (NasdaqGS:GEVA) from Hunt BioVentures, LP and others for $8.4 billion on May 5, 2015. The consortium of shareholders include Baker Brothers Investments, Capital Research Global Investors, Cordova Ventures, New Leaf Venture Partners, L.L.C.. Alexion will acquire all of the outstanding shares of common stock of Synageva through an exchange offer, followed ...
Fidelity Management & Research Company
Hunt BioVentures, LP
New Leaf Venture Partners, L.L.C.
TD Javelin Capital Fund II, L.P.
TD Lighthouse Capital Fund, L.P.
Tullis Health Investors Inc.
Tullis-Dickerson Capital Focus II, L.P.
Sullivan & Cromwell LLP
|Croda International PLC||2,778 GBp||+26.00|
|Dr Reddy's Laboratories Ltd||3,561 INR||-12.45|
|Sigma-Aldrich Corp||$139.44 USD||+0.09|
|Symrise AG||€56.09 EUR||+0.346|
|United Therapeutics Corp||$172.93 USD||-1.02|
|View Industry Companies|